Cargando…
Monoclonal antibodies capable of binding SARS‐CoV‐2 spike protein receptor‐binding motif specifically prevent GM‐CSF induction
A severe acute respiratory syndrome (SARS)‐like coronavirus 2 (SARS‐CoV‐2) has recently caused a pandemic COVID‐19 disease that infected approximately 94 million and killed more than 2,000,000 people worldwide. Like the SARS‐CoV, SARS‐CoV‐2 also employs a receptor‐binding motif (RBM) of its envelope...
Autores principales: | Qiang, Xiaoling, Zhu, Shu, Li, Jianhua, Chen, Weiqiang, Yang, Huan, Wang, Ping, Tracey, Kevin J., Wang, Haichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251270/ https://www.ncbi.nlm.nih.gov/pubmed/33759207 http://dx.doi.org/10.1002/JLB.3COVCRA0920-628RR |
Ejemplares similares
-
Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction.
por: Qiang, Xiaoling, et al.
Publicado: (2020) -
TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID‐19 patients
por: Assmann, Jorn L.J.C., et al.
Publicado: (2021) -
Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines
por: Li, Jianhua, et al.
Publicado: (2021) -
Headache and pleocytosis in CSF associated with COVID-19: case report
por: de Oliveira, Felipe Araújo Andrade, et al.
Publicado: (2020) -
Bell’s palsy following COVID-19 vaccination with high CSF antibody response
por: Obermann, Mark, et al.
Publicado: (2021)